Summit Therapeutics Statistics
Total Valuation
SMMT has a market cap or net worth of $13.86 billion. The enterprise value is $13.64 billion.
Important Dates
The last earnings date was Wednesday, October 30, 2024, before market open.
| Earnings Date | Oct 30, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SMMT has 745.51 million shares outstanding. The number of shares has increased by 31.11% in one year.
| Shares Outstanding | 745.51M |
| Shares Change (YoY) | +31.11% |
| Shares Change (QoQ) | -0.59% |
| Owned by Insiders (%) | 79.27% |
| Owned by Institutions (%) | 9.96% |
| Float | 113.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 69.03 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.56 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.03 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | -44.51% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.87M |
| Employee Count | 105 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +865.71% in the last 52 weeks. The beta is -0.97, so SMMT's price volatility has been lower than the market average.
| Beta (5Y) | -0.97 |
| 52-Week Price Change | +865.71% |
| 50-Day Moving Average | 19.85 |
| 200-Day Moving Average | 9.55 |
| Relative Strength Index (RSI) | 43.92 |
| Average Volume (20 Days) | 2,859,786 |
Short Selling Information
| Short Interest | 15.45M |
| Short Previous Month | 16.34M |
| Short % of Shares Out | 13.29% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.68 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -181.54M |
| Pretax Income | -161.69M |
| Net Income | -196.63M |
| EBITDA | -181.45M |
| EBIT | -181.54M |
| Earnings Per Share (EPS) | -$0.28 |
Full Income StatementBalance Sheet
The company has $325.47 million in cash and $108.71 million in debt, giving a net cash position of $216.76 million or $0.29 per share.
| Cash & Cash Equivalents | 325.47M |
| Total Debt | 108.71M |
| Net Cash | 216.76M |
| Net Cash Per Share | $0.29 |
| Equity (Book Value) | 195.08M |
| Book Value Per Share | 0.27 |
| Working Capital | n/a |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$112.86 million and capital expenditures -$128,000, giving a free cash flow of -$112.99 million.
| Operating Cash Flow | -112.86M |
| Capital Expenditures | -128,000 |
| Free Cash Flow | -112.99M |
| FCF Per Share | -$0.15 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |